Pande Vijay Satyanand
SEC CIK 1840663 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BIOA | BioAge Labs, Inc. | Dir | 1.12M | $20.53M | — | 3 | 2024-09-27 | 2024-10-01 |
Most active insiders at BIOA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fortney Kristen | CEO, Dir | — | $4.22M |
| 2 | Barton Shane | Principal Accounting Off | — | $1.58M |
| 3 | RUBIN PAUL D | Chief Medical Off | — | $1.46M |
| 4 | GOLDSTEIN DOV A MD | CFO | — | $531.8K |
Pande Vijay Satyanand made no open-market trades at BIOA in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-10-03 | 2024-10-01+ | BIOA | BioAge Labs, Inc. | Pande Vijay Satyanand | Dir | P - Purchase | $19.75 | +219.2K | 1.12M | +24% | +$4.33M |
| DMI | 2024-09-27 | 2024-09-27 | BIOA | BioAge Labs, Inc. | Pande Vijay Satyanand | Dir | C - Cnv Deriv | — | +2.11M | 655.3K | New | — |
| DI | 2024-09-27 | 2024-09-27 | BIOA | BioAge Labs, Inc. | Pande Vijay Satyanand | Dir | P - Purchase | $18.00 | +900.0K | 900.0K | New | +$16.20M |
Purchase Sale Sale after option exercise All abbreviations